Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Cash from Discontinued Operations (2022 - 2023)

Bioventus (BVS) has disclosed Cash from Discontinued Operations for 2 consecutive years, with 2169000.0 as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Cash from Discontinued Operations changed N/A year-over-year to 2169000.0, compared with a TTM value of 2169000.0 through Dec 2023, down 1.83%, and an annual FY2023 reading of 2169000.0, down 1.83% over the prior year.
  • Cash from Discontinued Operations was 2169000.0 for Q2 2023 at Bioventus, down from 1271000.0 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at 859000.0 in Q4 2022 and bottomed at 2169000.0 in Q2 2023.